AT372086B - Verfahren zur herstellung neuer propanonderivate - Google Patents

Verfahren zur herstellung neuer propanonderivate

Info

Publication number
AT372086B
AT372086B AT0133279A AT133279A AT372086B AT 372086 B AT372086 B AT 372086B AT 0133279 A AT0133279 A AT 0133279A AT 133279 A AT133279 A AT 133279A AT 372086 B AT372086 B AT 372086B
Authority
AT
Austria
Prior art keywords
producing new
propanone derivatives
propanone
derivatives
producing
Prior art date
Application number
AT0133279A
Other languages
English (en)
Other versions
ATA133279A (de
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11995644&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT372086(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Publication of ATA133279A publication Critical patent/ATA133279A/de
Application granted granted Critical
Publication of AT372086B publication Critical patent/AT372086B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT0133279A 1978-02-22 1979-02-21 Verfahren zur herstellung neuer propanonderivate AT372086B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1930378A JPS54125630A (en) 1978-02-22 1978-02-22 Novel propanone derivative*its manufacture and medical composition containing it as active component

Publications (2)

Publication Number Publication Date
ATA133279A ATA133279A (de) 1983-01-15
AT372086B true AT372086B (de) 1983-08-25

Family

ID=11995644

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0133279A AT372086B (de) 1978-02-22 1979-02-21 Verfahren zur herstellung neuer propanonderivate

Country Status (17)

Country Link
US (2) US4277474A (de)
EP (1) EP0004000B2 (de)
JP (1) JPS54125630A (de)
AR (1) AR221080A1 (de)
AT (1) AT372086B (de)
AU (1) AU530412B2 (de)
BR (1) BR7901124A (de)
CA (1) CA1120487A (de)
DE (1) DE2967306D1 (de)
DK (1) DK77679A (de)
ES (1) ES477882A1 (de)
IL (1) IL56664A (de)
MX (1) MX5399E (de)
NZ (1) NZ189721A (de)
PH (1) PH15114A (de)
SU (1) SU873873A3 (de)
ZA (1) ZA79778B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS184021B1 (en) * 1973-07-19 1978-07-31 Jan Drkal Rolling machine for cross tapered rolling
DE3019497A1 (de) * 1980-05-22 1981-11-26 Bayer Ag, 5090 Leverkusen Aminopropiophenon-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
JPS5944371A (ja) * 1982-09-07 1984-03-12 Dainippon Pharmaceut Co Ltd １―フエニル―２―メチル―３―（１―ピロリジニル）―１―プロパノン誘導体
JPS59190981A (ja) * 1983-04-15 1984-10-29 Hokuriku Seiyaku Co Ltd ３−ピロリジノ置換プロピオフエノン誘導体
JPS59190980A (ja) * 1983-04-15 1984-10-29 Hokuriku Seiyaku Co Ltd ２’−クロロ−３−アミノ−２−メチル置換プロピオフエノン誘導体
HU33131A (de) * 1984-01-26 1984-10-29
NL8400508A (nl) * 1984-02-17 1985-09-16 Philips Nv Audiotransmissiecircuit met als lijnspanningsstabilisator uitgevoerde zendversterker.
DE3436450A1 (de) * 1984-10-05 1986-04-10 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von p-aminoethylketonen
EP0200942B1 (de) * 1985-04-11 1993-08-25 Nippon Kayaku Kabushiki Kaisha Derivate eines Aminoketons
US5103022A (en) * 1985-04-11 1992-04-07 Nippon Kayaku Kabushiki Kaisha Process for producing an optically active aminoketone derivative
US5057535A (en) * 1985-04-11 1991-10-15 Nippon Kayaku Kabushiki Kaisha Derivatives of an aminoketone
US4650692A (en) * 1985-11-01 1987-03-17 Ashland Oil, Inc. Metal-sulfonate/piperidine derivative combination protective coatings
JPH03115267A (ja) * 1989-09-28 1991-05-16 Maruho Kk プロピオフエノン誘導体、その製造方法、それを含む中枢性筋弛緩剤および抗痙攣剤
WO1999003835A1 (fr) * 1997-07-18 1999-01-28 Nippon Kayaku Kabushiki Kaisha Derives cetoniques aromatiques et leurs utilisations
WO1999045914A1 (fr) * 1998-03-13 1999-09-16 Maruho Kabushikikaisha Derive alkylamine et agent anesthesique utilisant ce derive
GB9808447D0 (en) * 1998-04-18 1998-06-17 Zeneca Ltd Process
CN1869002A (zh) * 2005-05-27 2006-11-29 中国科学院上海药物研究所 一类非甾体雄激素受体调节剂、其制备方法和用途
EP2865381A1 (de) 2006-05-18 2015-04-29 Pharmacyclics, Inc. ITK-Hemmer zur Behandlung von bösartigen Blutzellenerkrankungen
US7858666B2 (en) 2007-06-08 2010-12-28 Mannkind Corporation IRE-1α inhibitors
US10882863B2 (en) 2016-05-13 2021-01-05 The Trustees Of Columbia University In The City Of New York Compounds for reducing c-Myc in c-Myc overexpressing cancers background
IT201600098338A1 (it) * 2016-09-30 2018-03-30 Univ Degli Studi Padova Composti 1-fenilpropanone e loro impiego

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2282907A (en) * 1941-05-01 1942-05-12 Us Rubber Co Parasiticide
US2771391A (en) * 1953-08-20 1956-11-20 Allied Lab Inc Physiologically active p-alkoxy-beta-piperidinopropiophenones causing cns depressantand anesthetic effects in animals
BE623404A (de) * 1960-04-26
FR1301863A (fr) * 1961-06-29 1962-08-24 Science Union & Cie Aminocétones substituées et leurs procédés de préparation
US3151124A (en) * 1961-11-20 1964-09-29 Ciba Geigy Corp Alpha oxy-beta alkyl-gamma tertiary amino-alpha phenyl propanes
GB1142474A (en) * 1965-03-24 1969-02-05 Ferrosan Ab Production of piperidino-butyrophenones
GB1115992A (en) * 1965-03-26 1968-06-06 Lafon Labor Improvements in or relating to n-piperidino-alkoxyacetophenones
US3417087A (en) * 1965-12-27 1968-12-17 Research Corp 3(aminopropionyl)benzothiophenes
US3903092A (en) * 1966-03-02 1975-09-02 Aspro Nicholas Ltd 2-Tertiaryamino-1-(benzo{8 b{9 thienyl)ethanols
US3495015A (en) * 1967-11-17 1970-02-10 American Cyanamid Co Treatment of depression with 3-substituted amino-2-phenylpropiophenones
GB1213963A (en) * 1968-03-28 1970-11-25 Richter Gedeon Vegyeszet Aromatic amino ketones
US3637712A (en) * 1970-01-26 1972-01-25 Bristol Myers Co Piperidylpropanol compounds
FR2138488A1 (en) * 1971-05-27 1973-01-05 Lipha 1-(5-indanyl)-omega-aminoalkanes - with tranquillizing activity
FR2150594A1 (en) * 1971-08-27 1973-04-13 Delalande Sa Omega-amino-1,2-diphenyl-1-alkanones - with analgesic antiinflammatory anti-ulcer,bronchodilator,spasmolytic and hypotensive
HU166289B (de) * 1973-01-15 1975-02-28
US3995047A (en) * 1973-12-14 1976-11-30 Eisai Co., Ltd. Propiophenone derivatives in the treatment of pathological muscular conditions
JPS5527914B2 (de) * 1973-12-14 1980-07-24
FR2305981A1 (fr) * 1975-04-03 1976-10-29 Innothera Lab Sa Nouvelles benzothienyl aminoethyl cetones, leur procede de preparation et leur application en therapeutique
DD124521A1 (de) * 1976-03-16 1977-03-02

Also Published As

Publication number Publication date
JPS54125630A (en) 1979-09-29
DK77679A (da) 1979-08-23
NZ189721A (en) 1981-11-19
BR7901124A (pt) 1979-09-11
IL56664A0 (en) 1979-05-31
IL56664A (en) 1984-01-31
DE2967306D1 (en) 1985-01-10
ES477882A1 (es) 1979-10-16
EP0004000B2 (de) 1988-06-15
AR221080A1 (es) 1980-12-30
JPS6256143B2 (de) 1987-11-24
US4563454A (en) 1986-01-07
AU530412B2 (en) 1983-07-14
AU4451779A (en) 1979-08-30
EP0004000B1 (de) 1984-11-28
EP0004000A1 (de) 1979-09-19
PH15114A (en) 1982-08-10
ZA79778B (en) 1980-03-26
SU873873A3 (ru) 1981-10-15
MX5399E (es) 1983-07-12
CA1120487A (en) 1982-03-23
ATA133279A (de) 1983-01-15
US4277474A (en) 1981-07-07

Similar Documents

Publication Publication Date Title
AT371817B (de) Verfahren zur herstellung neuer ergolinderivate
AT373599B (de) Verfahren zur herstellung neuer rifamycinderivate
AT372094B (de) Verfahren zur herstellung neuer corticoid-21halogen-17-alkylcarbonate
AT372086B (de) Verfahren zur herstellung neuer propanonderivate
AT362364B (de) Verfahren zur herstellung neuer phenylimi- dazolidinonderivate
AT368755B (de) Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate
AT373251B (de) Verfahren zur herstellung neuer d-6-n-propylergoline
ATA246780A (de) Verfahren zur herstellung neuer pyrazinobenzodiazepine
AT367403B (de) Verfahren zur herstellung neuer chinolin-2onderivate
AT358601B (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
AT362389B (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
ATA90478A (de) Verfahren zur herstellung neuer everninomicin- derivate
AT376217B (de) Verfahren zur herstellung neuer 3-chlorchinolinderivate
AT356294B (de) Verfahren zur herstellung neuer ergolinderivate
AT380014B (de) Verfahren zur herstellung neuer oxazolidin-2-on- derivate
AT376683B (de) Verfahren zur herstellung neuer 1-oxa-4-aza-2,6- disilacyclohexane
AT362798B (de) Verfahren zur herstellung neuer nitrosoharnstoff-derivate
PT67639A (de) Verfahren zur herstellung neuer indolylglyoxylsaeurederivate
AT370085B (de) Verfahren zur herstellung neuer aminobenzoesaeure- derivaten
AT381932B (de) Verfahren zur herstellung neuer 1-sulfo-2-oxoazetidin-derivate
AT376658B (de) Verfahren zur herstellung neuer carboxyphenyloder -toluylsulfoniumsalze
AT372386B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate
AT367767B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate
ATA947076A (de) Verfahren zur herstellung neuer ergolinderivate
ATA229781A (de) Verfahren zur herstellung neuer glucosederivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties